biofield spacer biofield spacer
Benefits of BDS to the Patient

  1. Identifies cancers currently missed by mammography and ultrasound. Biofield currently identified 119 out of 149 cancers. Whereas the current diagnostic technique only detected 88 out of 149 cancers. (BDS) identified 30% more cancers
  2. Non-invasive, painless and objective breast cancer diagnostic test with rapid results
    (15 minutes)
  3. Direct scientific measurement of cellular and molecular activity of breast lesions
       - Detects level of cell division / proliferation.
  4. Works well in younger women where x-ray imaging has major difficulties
  5. Safe testing allows the patient to have tests administered as frequently as needed without any risks to the patient’s health.
  6. Up to ten times less expensive than currently used breast cancer screening procedures